Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery

Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant... INTRODUCTIONUterine carcinosarcoma (UCS) is a rare but aggressive type of high‐grade endometrial cancer, and represents a disease of epithelial‐mesenchymal transition with the sarcoma element arising and dedifferentiated from the carcinoma component. Aggressiveness of UCS is clinically reflected in its stage distribution of tumors: unlike low‐grade endometrial cancer where the majority of tumors present with early stage disease, nearly half of UCS cases are advanced‐stage, including more than 10% with stage IV disease.Regardless of cancer stage, the standard treatment approach for high‐grade endometrial cancer including UCS is primary surgery consisting of hysterectomy, bilateral salpingo‐oophorectomy, lymphadenectomy, and/or resection of metastatic tumor implants if present. However, while primary surgical treatment is generally preferred, patients with stage IV disease are often not suitable surgical candidates for various reasons. These include presence of extensive disease burden and distant parenchymal metastasis, poor performance status, or deconditioning, and extensive medical comorbidity. All of these factors reflect the unique characteristics of UCS; specifically, that UCS is more common in elderly women and often demonstrates wide‐spread tumor progression.Neoadjuvant chemotherapy is an alternative treatment approach for patients who are not suitable for primary surgical treatment. The role of neoadjuvant chemotherapy has been studied in various types of gynecologic malignancy http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Surgical Oncology Wiley

Loading next page...
 
/lp/wiley/survival-outcome-of-women-with-stage-iv-uterine-carcinosarcoma-who-x0xW08K6ri
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
0022-4790
eISSN
1096-9098
D.O.I.
10.1002/jso.24861
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONUterine carcinosarcoma (UCS) is a rare but aggressive type of high‐grade endometrial cancer, and represents a disease of epithelial‐mesenchymal transition with the sarcoma element arising and dedifferentiated from the carcinoma component. Aggressiveness of UCS is clinically reflected in its stage distribution of tumors: unlike low‐grade endometrial cancer where the majority of tumors present with early stage disease, nearly half of UCS cases are advanced‐stage, including more than 10% with stage IV disease.Regardless of cancer stage, the standard treatment approach for high‐grade endometrial cancer including UCS is primary surgery consisting of hysterectomy, bilateral salpingo‐oophorectomy, lymphadenectomy, and/or resection of metastatic tumor implants if present. However, while primary surgical treatment is generally preferred, patients with stage IV disease are often not suitable surgical candidates for various reasons. These include presence of extensive disease burden and distant parenchymal metastasis, poor performance status, or deconditioning, and extensive medical comorbidity. All of these factors reflect the unique characteristics of UCS; specifically, that UCS is more common in elderly women and often demonstrates wide‐spread tumor progression.Neoadjuvant chemotherapy is an alternative treatment approach for patients who are not suitable for primary surgical treatment. The role of neoadjuvant chemotherapy has been studied in various types of gynecologic malignancy

Journal

Journal of Surgical OncologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial